(Q46669787)

English

Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval

scientific article published on 25 August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16123089

Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16123089

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

status migrainosus

1 reference

based on heuristic

inferred from title

8

object named as

Nappi G

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

author name string

Nappi RE

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16123089

Sances G

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16123089

Brundu B

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16123089

De Taddei S

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16123089

Sommacal A

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16123089

Ghiotto N

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16123089

Polatti F

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16123089

language of work or name

0 references

publication date

25 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16123089

Human Reproduction

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16123089

20

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16123089

12

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16123089

3423-3428

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16123089

Estrogen fluctuations, oral contraceptives and borderline personality

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI260

21 January 2018

Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI260

21 January 2018

Menstruation, sex hormones, and migraine

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI260

21 January 2018

Oestrogen and attacks of migraine with and without aura

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI260

21 January 2018

Prevalence of migraine on each day of the natural menstrual cycle

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI260

21 January 2018

Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI260

21 January 2018

Evolution and treatment of migraine with oral contraceptives

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI260

21 January 2018

Estrogen actions throughout the brain

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI260

21 January 2018

Neuroendocrine response to the serotonin agonist M-chlorophenylpiperazine in women with menstrual status migrainosus

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI260

21 January 2018

Effect of oral contraceptives on the urinary excretion of biochemical markers indicating vasoactive action.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI260

21 January 2018

Serotonin metabolism and depression in oral contraceptive users.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI260

21 January 2018

Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI260

21 January 2018

Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI260

21 January 2018

Stress, serotonergic function, and mood in users of oral contraceptives.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI260

21 January 2018

Recommendations on the Risk of Ischaemic Stroke Associated With Use of Combined Oral Contraceptives and Hormone Replacement Therapy in Women With Migraine

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI260

21 January 2018

Identifiers

10.1093/HUMREP/DEI260

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16123089

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16123089

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46669787&oldid=2125424187"